NEURONES (NRO.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:NRO - FR0004050250 - Common Stock
42.8 EUR
-0.3 (-0.7%)
Overall NRO gets a fundamental rating of 6 out of 10. We evaluated NRO against 68 industry peers in the IT Services industry. NRO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, NRO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year NRO was profitable.
In the past year NRO had a positive cash flow from operations.
In the past 5 years NRO has always been profitable.
NRO had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NRO has a better Return On Assets (7.07%) than 76.47% of its industry peers.
NRO's Return On Equity of 13.67% is fine compared to the rest of the industry. NRO outperforms 63.24% of its industry peers.
With a decent Return On Invested Capital value of 11.36%, NRO is doing good in the industry, outperforming 77.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NRO is in line with the industry average of 11.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.07% | ||
| ROE | 13.67% | ||
| ROIC | 11.36% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
1.3 Margins
With a decent Profit Margin value of 6.10%, NRO is doing good in the industry, outperforming 69.12% of the companies in the same industry.
NRO's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 8.88%, NRO is in the better half of the industry, outperforming 66.18% of the companies in the same industry.
In the last couple of years the Operating Margin of NRO has remained more or less at the same level.
NRO has a Gross Margin of 99.93%. This is amongst the best in the industry. NRO outperforms 95.59% of its industry peers.
NRO's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.88% | ||
| PM (TTM) | 6.1% | ||
| GM | 99.93% |
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NRO is creating some value.
NRO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for NRO remains at a similar level compared to 5 years ago.
NRO has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.53 indicates that NRO is not in any danger for bankruptcy at the moment.
NRO has a better Altman-Z score (4.53) than 85.29% of its industry peers.
The Debt to FCF ratio of NRO is 0.57, which is an excellent value as it means it would take NRO, only 0.57 years of fcf income to pay off all of its debts.
NRO has a Debt to FCF ratio of 0.57. This is amongst the best in the industry. NRO outperforms 91.18% of its industry peers.
NRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NRO (0.08) is better than 85.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 4.53 |
ROIC/WACC1.44
WACC7.9%
2.3 Liquidity
NRO has a Current Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.31, NRO belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
A Quick Ratio of 2.31 indicates that NRO has no problem at all paying its short term obligations.
NRO has a better Quick ratio (2.31) than 92.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 |
3. Growth
3.1 Past
NRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.56%.
Measured over the past years, NRO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.23% on average per year.
NRO shows a small growth in Revenue. In the last year, the Revenue has grown by 7.39%.
NRO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.70% yearly.
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
3.2 Future
The Earnings Per Share is expected to grow by 8.04% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.57% on average over the next years.
EPS Next Y0%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.74%
Revenue Next 2Y6.12%
Revenue Next 3Y6.07%
Revenue Next 5Y5.57%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NRO is valuated rather expensively with a Price/Earnings ratio of 20.58.
NRO's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of NRO to the average of the S&P500 Index (26.77), we can say NRO is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.42, the valuation of NRO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NRO is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, NRO is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.58 | ||
| Fwd PE | 18.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NRO is valued a bit cheaper than the industry average as 73.53% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as NRO.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.39 | ||
| EV/EBITDA | 6.12 |
4.3 Compensation for Growth
The decent profitability rating of NRO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.83
EPS Next 2Y4.65%
EPS Next 3Y8.74%
5. Dividend
5.1 Amount
NRO has a Yearly Dividend Yield of 3.05%. Purely for dividend investing, there may be better candidates out there.
NRO's Dividend Yield is a higher than the industry average which is at 2.41.
NRO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
5.2 History
On average, the dividend of NRO grows each year by 82.05%, which is quite nice.
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
NRO pays out 57.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
NRO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.4%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPA:NRO (12/31/2025, 1:50:48 PM)
42.8
-0.3 (-0.7%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners13.92%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Revenue(TTM)832.18M
Net Income(TTM)50.74M
Analysts84
Price Target53.04 (23.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.4%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5%
EPS NY rev (3m)5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.58 | ||
| Fwd PE | 18.42 | ||
| P/S | 1.25 | ||
| P/FCF | 14.39 | ||
| P/OCF | 12.34 | ||
| P/B | 2.81 | ||
| P/tB | 3.37 | ||
| EV/EBITDA | 6.12 |
EPS(TTM)2.08
EY4.86%
EPS(NY)2.32
Fwd EY5.43%
FCF(TTM)2.97
FCFY6.95%
OCF(TTM)3.47
OCFY8.1%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)N/A
PEG (5Y)1.83
Graham Number26.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.07% | ||
| ROE | 13.67% | ||
| ROCE | 15.75% | ||
| ROIC | 11.36% | ||
| ROICexc | 28.09% | ||
| ROICexgc | 41.87% | ||
| OM | 8.88% | ||
| PM (TTM) | 6.1% | ||
| GM | 99.93% | ||
| FCFM | 8.69% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexgc growth 3YN/A
ROICexgc growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 68.18% | ||
| Cap/Sales | 1.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.17% | ||
| Profit Quality | 142.58% | ||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 | ||
| Altman-Z | 4.53 |
F-Score7
WACC7.9%
ROIC/WACC1.44
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y0%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.74%
Revenue Next 2Y6.12%
Revenue Next 3Y6.07%
Revenue Next 5Y5.57%
EBIT growth 1Y0.45%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year17.11%
EBIT Next 3Y14.47%
EBIT Next 5Y11.67%
FCF growth 1Y13.09%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.34%
OCF growth 3Y9.37%
OCF growth 5Y6.59%
NEURONES / NRO.PA FAQ
What is the fundamental rating for NRO stock?
ChartMill assigns a fundamental rating of 6 / 10 to NRO.PA.
Can you provide the valuation status for NEURONES?
ChartMill assigns a valuation rating of 3 / 10 to NEURONES (NRO.PA). This can be considered as Overvalued.
Can you provide the profitability details for NEURONES?
NEURONES (NRO.PA) has a profitability rating of 7 / 10.
What is the financial health of NEURONES (NRO.PA) stock?
The financial health rating of NEURONES (NRO.PA) is 9 / 10.
What is the expected EPS growth for NEURONES (NRO.PA) stock?
The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to decline by 0% in the next year.